Cim LLC lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.1% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 20,443 shares of the medical equipment provider’s stock after selling 24 shares during the period. Intuitive Surgical comprises about 4.3% of Cim LLC’s investment portfolio, making the stock its 7th biggest holding. Cim LLC’s holdings in Intuitive Surgical were worth $11,664,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Oregon Public Employees Retirement Fund increased its holdings in Intuitive Surgical by 31,963.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 14,679,377 shares of the medical equipment provider’s stock valued at $31,000 after buying an additional 14,633,595 shares during the last quarter. Stone House Investment Management LLC purchased a new stake in Intuitive Surgical during the first quarter valued at approximately $31,000. Laurel Wealth Advisors LLC purchased a new stake in Intuitive Surgical during the fourth quarter valued at approximately $32,000. Athena Capital Advisors LLC purchased a new stake in Intuitive Surgical during the fourth quarter valued at approximately $33,000. Finally, Ellis Investment Partners LLC purchased a new stake in Intuitive Surgical during the first quarter valued at approximately $34,000. Hedge funds and other institutional investors own 84.85% of the company’s stock.
In other Intuitive Surgical news, VP Jamie Samath sold 2,236 shares of the stock in a transaction on Thursday, February 21st. The shares were sold at an average price of $547.36, for a total transaction of $1,223,896.96. Following the completion of the transaction, the vice president now owns 636 shares in the company, valued at $348,120.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Curet Myriam sold 2,200 shares of the stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $493.26, for a total transaction of $1,085,172.00. Following the transaction, the executive vice president now owns 3,101 shares of the company’s stock, valued at approximately $1,529,599.26. The disclosure for this sale can be found here. Insiders have sold 32,266 shares of company stock valued at $16,451,271 in the last quarter. 1.70% of the stock is owned by company insiders.
Shares of NASDAQ:ISRG traded up $0.70 during midday trading on Wednesday, reaching $488.05. 6,063 shares of the company were exchanged, compared to its average volume of 1,166,939. Intuitive Surgical, Inc. has a one year low of $430.24 and a one year high of $589.32. The firm has a market cap of $55.27 billion, a price-to-earnings ratio of 51.33, a P/E/G ratio of 4.18 and a beta of 1.02.
Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, April 18th. The medical equipment provider reported $2.61 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.70 by ($0.09). Intuitive Surgical had a return on equity of 17.33% and a net margin of 29.78%. The company had revenue of $974.00 million for the quarter, compared to the consensus estimate of $975.27 million. During the same quarter in the prior year, the company posted $2.44 EPS. Intuitive Surgical’s revenue was up 14.9% compared to the same quarter last year. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 9.4 EPS for the current year.
A number of brokerages have commented on ISRG. Cantor Fitzgerald set a $620.00 target price on shares of Intuitive Surgical and gave the company a “buy” rating in a report on Thursday, April 4th. BidaskClub raised shares of Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 23rd. Zacks Investment Research cut shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a research note on Tuesday, March 12th. Deutsche Bank initiated coverage on shares of Intuitive Surgical in a research note on Monday, April 1st. They issued a “buy” rating and a $630.00 price objective for the company. Finally, Raymond James reduced their price objective on shares of Intuitive Surgical from $630.00 to $610.00 and set an “outperform” rating for the company in a research note on Monday, April 22nd. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and fourteen have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $576.82.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
See Also: Trade Deficit
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.